The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
"Tomato God's Work: Water-soluble tomato concentrate has many uses"
"The potential of the Chinese market
China has a huge population, with hundreds of millions of people facing cardiovascular problems. Due to poor living habits and diet, the incidence of cardiovascular problems continues to rise. The application of water-soluble tomato concentrate has huge potential in the Chinese market and can provide more choices for the general public to maintain cardiovascular health."
https://baijiahao-baidu-com.translate.goog/s?id=1781868540006159201&wfr=spider&for=pc&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
https://baijiahao.baidu.com/s?id=1781868540006159201&wfr=spider&for=pc
Thank you
Http://postimg.cc/47zGS7NV
Presentation Rajaee Hospital.
Been a grind for sure, Take a look at the whole market Naz, there's little appetite for anything.
I was pondering 2009, when so much of folks savings entered the market due to interest rates on savings vanishing. Different story now.
As ever, we know what we're waiting for, By Health have invested heavily, they will want to sell big time when they launch.
So start a rumour Naz?
Or, like me, use the dips to buy more cheap shares. If you've done your research before investing, there's nothing to worry about. You just have to wait for the science to play out. As for how long that might take...
Why ,why this share is not going anywhere,,even if there was a rumour of a takeover would give some kind of hope .
Country No. 1 news channel now in Bengali
No more worries about heart attacks. It will decrease this time in medicine. A Bengali doctor and scientist made a breakthrough to reduce the risk of heart attack. Medical science is improving day by day. Inventions are drugs, vaccines for chronic diseases. And a noble boy of Bengal has been searching for a way to award the Nobel Prize to those who are holding the progress of this medical science. He is none other than Asim Dutta Roy, a resident of Gangnapur in Nadia and a medical scientist. Great discovery, Bengali doctor will reduce the risk of heart attack with tomatoes
https://www.youtube.com/watch?v=Uos8J7K1tPs
"nose in the trough" wellsite?
Personally I can't think of anyone more suited to mentoring a long term project in India. As for who is paying for his time. We don't yet know who is funding the project. Provexis? Chettinad Academy? or a third party???
For anyone who’s interested Informer over on advfn has posted a very good balanced account of the AGM . Some good and some not so good points made .
“From the detail of the Italian DSM collaboration it looks like DSM either plan to develop a rival product or are about to make a move. “. .Good luck with that , after having ff for 14 years they still can’t sell f all .
That’s Halloween out the way, M&S Xmas adverts in full swing. Soon be interims.
Fleck all volume post AGM, so must have been an IF cut and paste / jam tmrw special.
Good finds gixer, good to see the Prof still has his nose in the trough. Wonder who’s paying for his time.
From the detail of the Italian DSM collaboration it looks like DSM either plan to develop a rival product or are about to make a move.
W-come-back-kevin-promise-we-won’t-ask-again-$
Https://www-newsm-cn.translate.goog/shzx/202311/403607.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
https://science-china-com-cn.translate.goog/2023-11/02/content_42575936.htm?_x_tr_sch=http&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
KIEVS ? AGM
You must be a hyper vigilant optimist Gixer . A box of FF !
Someone bought £9.50 worth , two trades so far today so soon after a ramptastic RNS as well 😥
This Company popped up in a search the other day, Primovis Health AG Switzerland.
One of their "Market Ready Solutions" is a "Vegan Omega-3, Fruitflow 500 mg soft capsules" and is run by Thomas Stricker who worked for DSM for over 13 years.
Check out whats on the guys desk at the bottom of the page.
https://www.primovis.com/services/market-ready-solutions
Should also have copied this bit.
"Project for the purpose of assessing the cardio protective effect of Fruit flow on Doxorubicin-induced cardiotoxicity”
"Advertisement for Research/Project Assistant ‘Chettinad Academy of Research and Education
(India) and Provexis, UK collaborative Project"
https://care.edu.in/wp-content/uploads/2023/10/SP_Research_Assistant_Advt.pdf
Did anyone go to the Agm ,and ehat was the feeling like encouraging for long term,there hasn't been much comments abot the Agm this year
Kievs
come on, tell us about the AGM
W$
Snippet
Indena DSM partnership (includes gut health)
Hopefully, as Indena manufacture Fruitflow, we might see something from this partnership but who knows.
https://www.indena.com/2023/10/25/indena-partners-with-dsm-firmenich-to-develop-effective-market-ready-solutions/
https://www.indena.com/press-release/indena-dsm-firmenich-pioneer-a-new-age-of-nature-through-selected-market-inspired-botanical-solutions-for-human-health/
https://www.youtube.com/watch?v=_n6JiB6hFkM
https://www.dsm.com/human-nutrition/en/talking-nutrition/press-releases/2023-10-24-indena-and-dsm-firmenich-pioneer-a-new-age-of-nature-through-selected-market.html
Yep, well I've said my opinion about that a few times, it's my opinion that the significant multiples rely on BH orders in the near term. Effectively, DSM don't sell for the existing health claims, they are seeking a new niche in the gut health field. That is massive, but will not be quick to arrive IMHO
What about existing DSM customers/prospective customers? I think the RNS' imply that the existing DSM setup for platelet aggregation is expected to bring significant multiples of current total FF sales.
Hope Kievsky and others had a good time at the AGM.
We wait for ByHealth to light the touch paper on explosive growth of revenues. Also for DSM to develop the gut health claim.
Marking time until then.
Byhealth Co., Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 7,782.28 million compared to CNY 6,159.88 million a year ago. Revenue was CNY 7,782.28 million compared to CNY 6,159.88 million a year ago.